A 12-week Double-blind, Randomized, Multi-center Study Comparing the Efficacy and Safety of Once Monthly Subcutaneous AMG 334 Against Placebo in Adult Episodic Migraine Patients (EMPOwER)
收藏DataCite Commons2026-03-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012892/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is to evaluate the efficacy and safety of AMG334 in adult patients with episodic migraine
提供机构：
Vivli
创建时间：
2026-03-27
